These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7584479)

  • 1. Xenograft rejection--molecular mechanisms and therapeutic implications.
    Magee JC; Platt JL
    Ther Immunol; 1994 Jan; 1(1):45-58. PubMed ID: 7584479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanisms of xenotransplant rejection].
    Candinas D; Seebach JD
    Zentralbl Chir; 1999; 124(7):591-9. PubMed ID: 10474871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Xenotransplantation: physiopathology of hyperacute and differentiated rejection, and therapeutic perspectives].
    Malassagne B; Calmus Y; Houssin D; Weill B
    Pathol Biol (Paris); 2000 May; 48(4):377-82. PubMed ID: 10868402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular strategies for clinical xenotransplantation in cardiothoracic surgery.
    Hoopes CW; Platt JF
    Semin Thorac Cardiovasc Surg; 1996 Apr; 8(2):156-74. PubMed ID: 8672569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement mediates attenuation of endothelium-dependent relaxations in canine coronary arteries after porcine serum exposure: a mechanism for vascular thrombosis in xenograft hyperacute rejection.
    Cable DG; Hisamochi K; Schaff HV
    Circulation; 1997 Nov; 96(9 Suppl):II-58-63; discussion II-63-4. PubMed ID: 9386076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intervention strategies and agents mediating the prevention of xenorejection.
    Ghebremariam YT; Smith SA; Anderson JB; Kahn D; Kotwal GJ
    Ann N Y Acad Sci; 2005 Nov; 1056():123-43. PubMed ID: 16387682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The axis of interleukin 12 and gamma interferon regulates acute vascular xenogeneic rejection.
    Wang H; DeVries ME; Deng S; Khandaker MH; Pickering JG; Chow LH; Garcia B; Kelvin DJ; Zhong R
    Nat Med; 2000 May; 6(5):549-55. PubMed ID: 10802711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunological barriers to xenotransplantation.
    Platt JL
    Crit Rev Immunol; 1996; 16(4):331-58. PubMed ID: 8954254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pathogenesis of xenograft rejection.
    Makowka L; Cramer DV
    Clin Transplant; 1994 Apr; 8(2 Pt 2):145-54. PubMed ID: 8019030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathology of renal xenograft rejection in pig to non-human primate transplantation.
    Shimizu A; Yamada K
    Clin Transplant; 2006; 20 Suppl 15():46-52. PubMed ID: 16848876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral and cellular immunopathology of hepatic and cardiac hamster-into-rat xenograft rejection. Marked stimulation of IgM++bright/IgD+dull splenic B cells.
    Langer A; Valdivia LA; Murase N; Woo J; Celli S; Fung JJ; Starzl TE; Demetris AJ
    Am J Pathol; 1993 Jul; 143(1):85-98. PubMed ID: 7686346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement inhibition with an anti-C5 monoclonal antibody prevents acute cardiac tissue injury in an ex vivo model of pig-to-human xenotransplantation.
    Kroshus TJ; Rollins SA; Dalmasso AP; Elliott EA; Matis LA; Squinto SP; Bolman RM
    Transplantation; 1995 Dec; 60(11):1194-202. PubMed ID: 8525509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Xenotransplantation].
    Itsuo Y; Shugi H; Takaaki K; Masataka N; Yasushi N; Akiko K; Takaharu N; Taiki K; Chihiro K; Hiroshi T
    Nihon Geka Gakkai Zasshi; 1996 Nov; 97(11):1010-7. PubMed ID: 9010858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FK778 in experimental xenotransplantation: a detailed analysis of drug efficacy.
    Schrepfer S; Deuse T; Koch-Nolte F; Krieger T; Haddad M; Schäfer H; Pelletier MP; Robbins RC; Reichenspurner H
    J Heart Lung Transplant; 2007 Jan; 26(1):70-7. PubMed ID: 17234520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic engineering of endothelial cells to ameliorate xenograft rejection.
    Bach FH; Robson SC; Wrighton CJ; Stuhlmeier K; Ferran C; Winkler H
    Clin Transplant; 1996 Feb; 10(1 Pt 2):124-7. PubMed ID: 8680048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo IgM depletion by anti-mu monoclonal antibody therapy. The role of IgM in hyperacute vascular rejection of discordant xenografts.
    Soares M; Lu X; Havaux X; Baranski A; Reding R; Latinne D; Daha M; Lambotte L; Bach FH; Bazin H
    Transplantation; 1994 Apr; 57(7):1003-9. PubMed ID: 8165695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the alternative pathway of complement in hyperacute xenograft rejection of rabbit hearts by human blood.
    Forty J; White DJ; Wallwork J
    J Heart Lung Transplant; 1993; 12(2):283-6; discussion 286-7. PubMed ID: 8476902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in xenotransplantation.
    Cozzi E; Masroor S; Soin B; Vial C; White DJ
    Clin Nephrol; 2000 Apr; 53(4):suppl 13-8. PubMed ID: 10809429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of endothelial cells in hyperacute xenograft rejection.
    Geller RL; Bach FH; Vercellotti GM; Nistler RS; Bolman RM; Fischel RJ; Leventhal J; Platt JL
    Transplant Proc; 1992 Apr; 24(2):592. PubMed ID: 1566442
    [No Abstract]   [Full Text] [Related]  

  • 20. Xenotransplantation: role of natural immunity.
    Li S; Waer M; Billiau AD
    Transpl Immunol; 2009 Jun; 21(2):70-4. PubMed ID: 18992342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.